270 related articles for article (PubMed ID: 33528916)
21. Brahma-related gene 1-dependent STAT3 recruitment at IL-6-inducible genes.
Ni Z; Bremner R
J Immunol; 2007 Jan; 178(1):345-51. PubMed ID: 17182572
[TBL] [Abstract][Full Text] [Related]
22. Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.
Roy N; Malik S; Villanueva KE; Urano A; Lu X; Von Figura G; Seeley ES; Dawson DW; Collisson EA; Hebrok M
Genes Dev; 2015 Mar; 29(6):658-71. PubMed ID: 25792600
[TBL] [Abstract][Full Text] [Related]
23. Brg1 Enables Rapid Growth of the Early Embryo by Suppressing Genes That Regulate Apoptosis and Cell Growth Arrest.
Singh AP; Foley JF; Rubino M; Boyle MC; Tandon A; Shah R; Archer TK
Mol Cell Biol; 2016 Aug; 36(15):1990-2010. PubMed ID: 27185875
[TBL] [Abstract][Full Text] [Related]
24. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
[TBL] [Abstract][Full Text] [Related]
25. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
[TBL] [Abstract][Full Text] [Related]
26. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
[TBL] [Abstract][Full Text] [Related]
27. CK2-Dependent Phosphorylation of the Brg1 Chromatin Remodeling Enzyme Occurs during Mitosis.
Padilla-Benavides T; Haokip DT; Yoon Y; Reyes-Gutierrez P; Rivera-Pérez JA; Imbalzano AN
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019271
[TBL] [Abstract][Full Text] [Related]
28. BRG1 Is Dispensable for Sertoli Cell Development and Functions in Mice.
Wang S; Wang P; Liang D; Wang Y
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575410
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase.
Gao Y; Fotovati A; Lee C; Wang M; Cote G; Guns E; Toyota B; Faury D; Jabado N; Dunn SE
Mol Cancer Ther; 2009 Dec; 8(12):3276-84. PubMed ID: 19996271
[TBL] [Abstract][Full Text] [Related]
30. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
[TBL] [Abstract][Full Text] [Related]
31. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
Medina PP; Sanchez-Cespedes M
Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
[TBL] [Abstract][Full Text] [Related]
33. The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer.
Romero OA; Setien F; John S; Gimenez-Xavier P; Gómez-López G; Pisano D; Condom E; Villanueva A; Hager GL; Sanchez-Cespedes M
EMBO Mol Med; 2012 Jul; 4(7):603-16. PubMed ID: 22407764
[TBL] [Abstract][Full Text] [Related]
34. A novel role of Brg1 in the regulation of SRF/MRTFA-dependent smooth muscle-specific gene expression.
Zhang M; Fang H; Zhou J; Herring BP
J Biol Chem; 2007 Aug; 282(35):25708-16. PubMed ID: 17599918
[TBL] [Abstract][Full Text] [Related]
35. BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer.
Zhu X; Sun L; Lan J; Xu L; Zhang M; Luo X; Gong J; Wang G; Yuan X; Hu J; Wang J
Oncotarget; 2016 Jun; 7(24):36501-36509. PubMed ID: 27145366
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-1 suppresses glioblastoma in preclinical models by targeting fibronectin.
Yang CH; Wang Y; Sims M; Cai C; Pfeffer LM
Cancer Lett; 2019 Nov; 465():59-67. PubMed ID: 31491450
[TBL] [Abstract][Full Text] [Related]
37. O6-Methylguanine-DNA methyltransferase is a novel negative effector of invasion in glioblastoma multiforme.
Chahal M; Abdulkarim B; Xu Y; Guiot MC; Easaw JC; Stifani N; Sabri S
Mol Cancer Ther; 2012 Nov; 11(11):2440-50. PubMed ID: 22986464
[TBL] [Abstract][Full Text] [Related]
38. The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways.
Alessio N; Squillaro T; Cipollaro M; Bagella L; Giordano A; Galderisi U
Oncogene; 2010 Oct; 29(40):5452-63. PubMed ID: 20697355
[TBL] [Abstract][Full Text] [Related]
39. Loss of BRG1 (
Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J
Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913
[TBL] [Abstract][Full Text] [Related]
40. SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance.
Yu F; Li G; Gao J; Sun Y; Liu P; Gao H; Li P; Lei T; Chen Y; Cheng Y; Zhai X; Sayari AJ; Huang H; Mu Q
Cell Prolif; 2016 Apr; 49(2):195-206. PubMed ID: 26923184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
